Pointe Capital Management LLC Amgen Inc Transaction History

Pointe Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $20,321 - $24,768	90 New	90 $21,000
Q4 2017 Jan 12, 2018	SELL	$168.79 - $188.59 $236,306 - $264,026	-1,400 Closed	0 $0
Q3 2017 Oct 16, 2017	BUY	$167.29 - $191.0 $234,206 - $267,400	1,400	1,400 $261,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $151B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Pointe Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Pointe Capital Management LLC with notifications on news.